Disease · MONDO_0006668
Comparisons in its trials42
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 42
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Moxifloxacin AF vs Vehicle: deaths from any cause | 0 of 593 | 0 of 586 | 1,179 | NCT00759148 | Trial comparisons |
| Moxifloxacin AF vs Vehicle: serious adverse events | 0 of 593 | 0 of 586 | 1,179 | NCT00759148 | Trial comparisons |
| Moxifloxacin Solution vs Besifloxacin Suspension: serious adverse events | 1 of 579 | 1 of 582 | 1,161 | NCT00348348 | Trial comparisons |
| Moxifloxacin vs Ofloxacin: serious adverse events | 1 of 489 | 0 of 493 | 982 | NCT01573910 | Trial comparisons |
| ISV-403 vs Vehicle: serious adverse events | 1 of 442 | 1 of 432 | 874 | NCT00347932 | Trial comparisons |
| Gatifloxacin 0.5% Eye Drops vs Placebo Eye Drops: serious adverse events | 2 of 429 | 0 of 427 | 856 | NCT00518089 | Trial comparisons |
| AzaSite vs Tobramycin: serious adverse events | 0 of 365 | 0 of 378 | 743 | NCT00105469 | Trial comparisons |
| AzaSite vs Vehicle: serious adverse events | 0 of 333 | 2 of 350 | 683 | NCT00105534 | Trial comparisons |
| Gatifloxacin 0.5% Eye Drops vs Placebo Eye Drops: serious adverse events | 0 of 288 | 1 of 289 | 577 | NCT00509873 | Trial comparisons |
| Moxifloxacin Solution vs Besifloxacin Suspension: Clinical Resolution | 167 of 281 | 147 of 252 | 533 | NCT00348348 | Trial comparisons |
| Moxifloxacin Solution vs Besifloxacin Suspension: Microbial Eradication | 238 of 281 | 220 of 252 | 533 | NCT00348348 | Trial comparisons |
| Moxifloxacin Solution vs Besifloxacin Suspension: Clinical Resolution | 236 of 281 | 213 of 252 | 533 | NCT00348348 | Trial comparisons |
| Moxifloxacin Solution vs Besifloxacin Suspension: Microbial Eradication | 256 of 281 | 235 of 252 | 533 | NCT00348348 | Trial comparisons |
| Besifloxacin vs Vehicle: serious adverse events | 0 of 228 | 0 of 236 | 464 | NCT00972777 | Trial comparisons |
| ISV-403 vs Vehicle: Clinical Resolution of Baseline Bacterial Conjunctivitis | 90 of 199 | 63 of 191 | 390 | NCT00347932 | Trial comparisons |
| ISV-403 vs Vehicle: Microbial Eradication of Baseline Bacterial Infection | 176 of 199 | 137 of 191 | 390 | NCT00347932 | Trial comparisons |
| ISV-403 vs Vehicle: Clinical Resolution of Baseline Bacterial Conjunctivitis | 168 of 199 | 132 of 191 | 390 | NCT00347932 | Trial comparisons |
| ISV-403 vs Vehicle: Microbial Eradication of Baseline Bacterial Infection | 182 of 199 | 114 of 191 | 390 | NCT00347932 | Trial comparisons |
| AzaSite vs Tobramycin: Number of Participants Who Achieved Clinical Resolution at Visit 3 | 127 of 159 | 123 of 157 | 316 | NCT00105469 | Trial comparisons |
| AzaSite vs Tobramycin: Number of Participants Who Achieved Bacterial Eradication at Visit 3 | 140 of 159 | 148 of 157 | 316 | NCT00105469 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0006668/comparisons